SUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Prospective TRISTAR Study

*Tennessee Retina, PC, Nashville, Tennessee

†Department F.-A. Forel for Environmental and Aquatic Sciences (DEFSE) and Institute for Environmental Sciences (ISE), University of Geneva, CH-1211, Geneva, Switzerland.

Reprint requests: Eric W. Schneider, MD, Tennessee Retina, PC 345 23rd Ave N #350, Nashville, TN 37203; e-mail: [email protected]

Supported by the research grant from Regeneron. The funding organization had no role in the design or conduct of this research.

Conflict of Interest(s): E. W. Schneider: Consultant, Carl Zeiss Meditec; Grant Support, Regeneron, Investigator, Genentech, Kodiak Sciences, RegenxBio. M. K. Thomas: None. F. M. Recchia: Speaker, Genentech, Investigator, Genentech, Kodiak Sciences, RegenxBio. D. A. Reichstein: Investigator, Genentech, Kodiak Sciences, RegenxBio. C. C. Awh: Consultant, Genentech, Grant Support, Regeneron; Investigator, Genentech, Kodiak Sciences, RegenxBio.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.retinajournal.com).

Presented at the American Society of Retina Specialists Annual Meeting, 2020, Paper Presentation.

留言 (0)

沒有登入
gif